Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
作者信息
van der Molen Thys, Postma Dirkje S, Martin Richard J, Herings Ron M C, Overbeek Jetty A, Thomas Victoria, Miglio Cristiana, Dekhuijzen Richard, Roche Nicolas, Guilbert Theresa, Israel Elliot, van Aalderen Wim, Hillyer Elizabeth V, van Rysewyk Simon, Price David B
机构信息
Department of General Practice, University of Groningen, University Medical Center, Groningen, The Netherlands.
University of Groningen, University Medical Center Groningen, Department Pulmonary Medicine and Tuberculosis, Groningen, The Netherlands.
出版信息
BMC Pulm Med. 2016 Jul 23;16(1):105. doi: 10.1186/s12890-016-0270-9.
Abstract
摘要
相似文献
1
Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
BMC Pulm Med. 2016 Jul 23;16(1):105. doi: 10.1186/s12890-016-0270-9.
2
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
BMC Pulm Med. 2016 May 17;16(1):80. doi: 10.1186/s12890-016-0234-0.
3
Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma.
Respir Med. 2013 Jul;107(7):987-1000. doi: 10.1016/j.rmed.2013.03.009. Epub 2013 May 3.
4
Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Int J Chron Obstruct Pulmon Dis. 2014 Oct 17;9:1163-86. doi: 10.2147/COPD.S68289. eCollection 2014.
5
Erratum: Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum].
Int J Chron Obstruct Pulmon Dis. 2022 Mar 7;17:489-490. doi: 10.2147/COPD.S363875. eCollection 2022.
6
Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Clin Exp Allergy. 2011 Nov;41(11):1521-32. doi: 10.1111/j.1365-2222.2011.03820.x. Epub 2011 Jul 14.
7
A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Ann Allergy Asthma Immunol. 2001 May;86(5):575-82. doi: 10.1016/S1081-1206(10)62907-9.
8
Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.
J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):721-31.e16. doi: 10.1016/j.jaip.2015.04.012. Epub 2015 May 29.
9
Cost-utility of inhaled corticosteroids in patients with moderate-to-severe asthma.
Expert Rev Pharmacoecon Outcomes Res. 2004 Oct;4(5):549-64. doi: 10.1586/14737167.4.5.549.
10
Extra-fine particle inhaled corticosteroids, pharma-cokinetics and systemic activity in children with asthma.
Pediatr Allergy Immunol. 2016 Feb;27(1):13-21. doi: 10.1111/pai.12491. Epub 2015 Nov 4.
本文引用的文献
1
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
BMC Pulm Med. 2016 May 17;16(1):80. doi: 10.1186/s12890-016-0234-0.
Zotero 插件